Assessment of coronary heart disease risk by combined analysis of coagulation factors
- 30 June 2008
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 198 (2), 294-300
- https://doi.org/10.1016/j.atherosclerosis.2007.12.062
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Does the oxidation of methionine in thrombomodulin contribute to the hypercoaguable state of smokers and diabetics?Medical Hypotheses, 2007
- TAFIa, PAI‐1 and α2‐antiplasmin: complementary roles in regulating lysis of thrombi and plasma clotsJournal of Thrombosis and Haemostasis, 2007
- MOLECULAR ASPECTS OF THROMBOSIS AND ANTITHROMBOTIC DRUGSCritical Reviews in Clinical Laboratory Sciences, 2005
- Inter-relation of coagulation factors and d-dimer levels in healthy individualsJournal of Thrombosis and Haemostasis, 2003
- Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis InhibitorPublished by Elsevier BV ,1998
- Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experienceJournal of Clinical Epidemiology, 1996
- Association of coagulation factors and inhibitors with carotid artery atherosclerosis early results of the Atherosclerosis Risk in Communities (ARIC) studyAnnals of Epidemiology, 1992
- Fibrinogen and risk of cardiovascular disease. The Framingham StudyPublished by American Medical Association (AMA) ,1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984